| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-5,316 | -5,615 | -5,716 | -6,894 | -6,667 |
|
Research and Development Expenses
|
-12,905 | -13,272 | -10,959 | -16,608 | -18,813 |
| Other Income/Expense, Operating
|
3,308 | 3,043 | 3,183 | 2,611 | 2,950 |
|
Operating Income/Expenses
|
-14,913 | -15,844 | -13,492 | -20,891 | -22,530 |
|
Total Operating Profit/Loss
|
-14,913 | -15,844 | -13,492 | -20,891 | -22,530 |
| Total Net Finance Income/Expense
|
101 | 152 | 355 | 465 | -241 |
| Net Investment Income
|
-65 | -65 | -11 | -28 | 3 |
| Irregular Income/Expenses
|
-1,942 | -- | -- | -- | -- |
|
Non-Operating Income/Expenses, Total
|
-1,906 | 87 | 344 | 437 | -238 |
|
Pretax Income
|
-16,817 | -15,756 | -13,148 | -20,454 | -22,769 |
|
Provision for Income Tax
|
50 | -3 | -40 | -56 | 38 |
|
Net Income from Continuing Operations
|
-16,767 | -15,759 | -13,188 | -20,510 | -22,731 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-16,767 | -15,759 | -13,188 | -20,510 | -22,731 |
|
Net Income after Non-Controlling/Minority Interests
|
-16,767 | -15,759 | -13,188 | -20,510 | -22,731 |
|
Net Income Available to Common Stockholders
|
-16,767 | -15,759 | -13,188 | -20,510 | -22,731 |
|
Dilution to Earnings
|
0 | 0 | 0 | 0 | 0 |
|
Diluted Net Income Available to Common Stockholders
|
-16,767 | -15,759 | -13,188 | -20,510 | -22,731 |
| Basic EPS
|
-0.43 | -0.42 | -0.40 | -0.65 | -0.74 |
| Diluted EPS
|
-0.43 | -0.42 | -0.40 | -0.65 | -0.74 |
|
Basic Weighted Average Shares Outstanding
|
38,407.3970 | 37,499.9780 | 33,254.5850 | 31,587.2400 | 30,898.1750 |
|
Diluted Weighted Average Shares Outstanding
|
38,407.3970 | 37,499.9780 | 33,254.5850 | 31,587.2400 | 30,898.1750 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-16,941 | -15,931 | -13,525 | -20,948 | -22,545 |
|
EBITDA
|
-15,215 | -14,146 | -11,697 | -19,162 | -20,969 |
|
Normalized EBITDA
|
-12,988 | -13,462 | -11,039 | -18,125 | -19,236 |
|
Normalized Income
|
-14,546.6209 | -15,246 | -12,694.5000 | -19,732.2500 | -21,000.8924 |
|
Total Unusual Items
|
2,227 | 684 | 658 | 1,037 | 1,733 |
|
Total Unusual Items Excluding Goodwill
|
2,227 | 684 | 658 | 1,037 | 1,733 |
|
Tax Effect of Unusual Items
|
6.6209 | 171 | 164.5000 | 259.2500 | 2.8924 |
12/31/2022 - 7/2/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade